REQUEST A DEMO
Total
USD $0.00
Search more companies

Emapharm S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Emapharm S.A. Profile Updated: February 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Emapharm S.A. is an enterprise based in Ecuador. Its main office is in Quito. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Emapharm S.A. was incorporated on February 15, 2017. Emapharm S.A. currently employs 3 (2024) people. There was a net sales revenue increase of 20.86% reported in Emapharm S.A.’s latest financial highlights for 2024. There was a total negative growth of 64.59% in Emapharm S.A.’s total assets over the same period. The net profit margin of Emapharm S.A. increased by 63.2% in 2024.

Headquarters
Avenida de los Shyris N34-382, la Tribuna Bldg. , Floor 601
Quito; Pichincha;

Contact Details: Purchase the Emapharm S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Emapharm S.A. report to view the information.
Registered Capital:
Purchase the Emapharm S.A. report to view the information.
Financial Auditors:
Purchase the Emapharm S.A. report to view the information.
Incorporation Date:
February 15, 2017
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Emapharm S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
20.86%
Total operating revenue
20.91%
Operating profit (EBIT)
29.27%
EBITDA
29.27%
Net Profit (Loss) for the Period
29.27%
Total Assets
-64.59%
Total Equity
-67.17%
Operating Profit Margin (ROS)
63.2%
Net Profit Margin
63.2%
Return on Equity (ROE)
-54.78%
Quick Ratio
-0.5%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?